General Information of DTT (ID: TT54ERL)

DTT Name Voltage-gated sodium channel alpha Nav1.6 (SCN8A) DTT Info
Gene Name SCN8A

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
3 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
NBI-921352 DMTTW9V Epileptic encephalopathy 8A62 Phase 2 [1]
PRAX-330 DMHIS3M Epilepsy 8A60-8A68 Phase 1 [2]
XEN901 DMRP9YF Epilepsy 8A60-8A68 Phase 1 [3]
------------------------------------------------------------------------------------
3 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
4,9-anhydro-tetrodotoxin DMEKI1B Discovery agent N.A. Investigative [4]
batrachotoxin DMYH9SU Discovery agent N.A. Investigative [5]
veratridine DMUF8JZ Discovery agent N.A. Investigative [5]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Clinical pipeline report, company report or official report of Neurocrine Biosciences
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Antibodies and venom peptides: new modalities for ion channels. Nat Rev Drug Discov. 2019 May;18(5):339-357.
4 The TTX metabolite 4,9-anhydro-TTX is a highly specific blocker of the Na(v1.6) voltage-dependent sodium channel. Am J Physiol Cell Physiol. 2007 Aug;293(2):C783-9.
5 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 583).